Ipsen announces the appointment of Keira Driansky as Executive Vice President and President North America, effective May 13, succeeding Stewart Campbell who will leave the pharmaceutical company to pursue other opportunities.

A former research scientist, Keira Driansky brings to the group extensive experience in leading commercial, development and investment teams across the healthcare sector.

She joins Ipsen, where she will be part of the executive leadership team (ELT), from AstraZeneca, where she spent the last 13 years leading teams in the US, Europe and in global functions.

Copyright (c) 2024 CercleFinance.com. All rights reserved.